Navigation Links
Valtrex Prevents the Need for C-Section among Women Infected With Genital Herpes

Researchers from the University of Texas, Southwestern Medical Center have found a new anti viral drug which prevents the necessity of a caesarean section //in pregnant woman who have a history of genital herpes.

The UT Southwestern study is the first large-scale confirmation that the drug valacyclovir hydrochloride (Valtrex) is effective in the last month of pregnancy, the researchers said.

The study appears in this month's issue of the journal Obstetrics and Gynecology. ‘I think this will help immensely in giving doctors stronger evidence in using this treatment,’ said Dr. Jeanne Sheffield, assistant professor of obstetrics and gynecology at UT Southwestern and lead author of the study. ‘Besides reducing the number of herpes outbreaks at birth, we also dropped the numbers of women without symptoms who were shedding the virus into the birth canal.’

Herpes, one of the most common sexually transmitted viral infections, causes periods of genital sores, followed by months or years of dormancy. It can't be cured, although the number and severity of outbreaks can be reduced through medication. Many women of reproductive age are unaware that they have the virus. In rare cases, infants can catch herpes simplex virus from the birth canal or genital region of the mother during birth, even when the mother isn't showing symptoms. Current medical protocol is to offer C-sections to all women with active genital herpes lesions at the time of delivery.

Nonetheless, 70 percent of neonatal herpes cases occur in infants of women who asymptomatically shed the virus near delivery, according to the researchers. ‘The whole goal of this study was to reduce active genital herpes lesions at delivery that require a Caesarean delivery to prevent neonatal herpes,’ Dr. Sheffield said. The UT Southwestern study, which involved 338 pregnant women with a history of genital herpes, was a randomized, double-blind trial, with neither the doctors nor the women
'"/>




Page: 1 2

Related medicine news :

1. Tea Prevents Skin Cancer
2. Use Of Sunscreen In Childhood And Prevents Future Skin Cancer
3. Research Shows Carbon Monoxide Prevents Inflammations
4. Polluted Water Prevents Men From Getting Married
5. Rush Study Shows That Interactions with Friends and Family Prevents Damaging Effects of Alzheimers disease
6. Fitness Prevents Alzheimers
7. Vegetarian Diet Prevents the Development of Atherosclerosis
8. Exercise in Space Prevents Kidney Stone Formation in Astronauts
9. Study Says - Blocking aP2 Protein Prevents Airway Diseases
10. Naloxone Prevents Heroin Overdose
11. A Drug That Prevents Blindness
Post Your Comments:
(Date:10/13/2008)...ir levels were lower than Alzheimer,s patients, he...althDay News) -- Parkinson,s disease patients are ...ients to have vitamin D deficiency, say researcher...Atlanta. , They compared vitamin D levels in 10...nd 99 healthy people matched for age and other fac...
(Date:10/13/2008)...., Oct. 13, 2008 /PRNewswire/ -- The AMERIGROUP Fo... of the School for Children with,Hidden Intelligen...,training program., SCHI is a state-approved, pri...ndicapped, underprivileged children with special n... and alleviate the suffering of the,most vulnerabl...
(Date:10/13/2008)...perium(TM) Market Leading Content Rights Managemen...g the Loop on Their Content Spend, WEST CHESTER, ...ed,today that a leading global pharmaceutical manu...logy to become the primary platform for the,secure...d reporting,analytics for their new product video ...
(Date:10/13/2008)...s a significant problem in daily life, survey show.../ -- Approximately,three-quarters of people living...roblem in daily life, according to a National Psor... survey of 426 individuals with psoriasis and psor...nfluences their daily lives, shapes their,feelings...
Breaking Medicine News(10 mins):Health News:Parkinson's Patients More Prone to Vitamin D Deficiency 2Health News:AMERIGROUP Foundation Supports the School for Children with Hidden Intelligence 2Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Psoriasis Foundation Releases 2008 Study Results 2
...ter announced today the start of the EASE (Exhale ...al, multi-center clinical trial to explore an inv...ally-invasive option for those suffering with adva...n experimental procedure called airway bypass desi...
...istinction of becoming a country with the highest ...rgency facilities for heart patients could save li...Health Organisation (WHO) reports, India is likely...tack capital of the world by 2010. "Cardiac disea...
...ls Inc. and Onyx Pharmaceuticals, Inc. today annou...ntly extended overall survival in patients with h...ncer versus those taking placebo by 44%. Results w...ting of the American Society of Clinical Oncology ...
...tails of two new investigational cancer therapies ...) meeting. AZD2281 (KU-0059436) is a small molecu... PARP is an enzyme involved in Base Excision Repa...air of DNA single-stranded breaks. Inhibiting this...
Other Medicine News:Health News:Airway Bypass Treatment for Emphysema - Study 2Health News:Nexavar Significantly Extends Survival of Liver Cancer Patients 2Health News:Astrazeneca's Investigational Cancer Therapies Revealed at ASCO 2Health News:Astrazeneca's Investigational Cancer Therapies Revealed at ASCO 3
(Date:10/10/2008)...EEK, Mich., Oct. 10 /- Diplomat Speci...ce has selected Diplomat,Specialty Pharmacy to be ...scale, national Therapy Optimization Study for Mul...ear TOP MS study, is to examine the benefits of a,...ompliance, adherence and,patient outcomes. Targete...
(Date:10/10/2008)...ass., Oct. 10 /- Boston Sci...the schedule of the Company,s major,events and pre...undation,s,(CRF) twentieth annual Transcatheter Ca...um, which runs from October 12 to 17 in Washington...de range of safety and,efficacy data on its TAXUS(...
(Date:10/9/2008)...ht Day 2008 focuses on the need to protect the eye...re/ -- Of the 45 million people worldwide who,are ...ers of them could,have avoided their blindness if ...view the Multimedia News Release, go to:, http://w...orld,s leader in eye care products and equipment, ...
(Date:10/9/2008)...ranslational Science Institute, Navigenics, Affyme...tudy, SAN DIEGO, Oct. 9 /- A consort...s have joined forces in a first-of-its-kind,resear...al genetic testing,on people who choose to receive...for developing certain diseases., Sponsored by Sc...
Breaking Medicine Technology:Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5CVS Caremark Corp to Pay 2436 7 Million to U S 23 States 26 D C to Settle Medicaid Prescription Drug Fraud Allegations 14636 1CVS Caremark Corp to Pay 2436 7 Million to U S 23 States 26 D C to Settle Medicaid Prescription Drug Fraud Allegations 14636 2New Foam Treatment for Varicose Veins 14633 1New Foam Treatment for Varicose Veins 14633 2MultiVu Video Feed 3A Stinky Sneakers Worth Big Money 21 14630 1MultiVu Video Feed 3A Stinky Sneakers Worth Big Money 21 14630 2Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 1Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 2Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 3Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 4Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 5Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future March 25 14626 6
...23, 2007 /PRNewswire-FirstCall/ -- Shire plc,annou...l system),the first and only non-oral medication ...ctivity Disorder (ADHD) in children aged 6,to 12 y...control,and tolerability, according to results of ...can Psychiatric Association (APA),annual meeting i...
...--(BUSINESS WIRE)--May 23, 2007 - Synta,Pharmaceut...mpany,focused on discovering, developing, and comm...edical conditions, today announced,that survival a...trial in metastatic melanoma of the Company,s lead...ted at the annual meeting of the,American Society ...
Other Medicine Technology:12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 212-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 312-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 412-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 512-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 612-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 712-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 812-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 9Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 2Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 3
... Volk Area Centralis® is excellent for critica...ization and changes from macular degeneration, ret...proliferative diabetic retinopathy and other retin...nt of these conditions providing excellent magnifi...
... original 130° QuadrAspheric lens has grown in...preferred wide field fundus laser lens. Its sleek ...age over competitive wide field lenses for periphe...ease of use. This lens is excellent for small pupi...
The Digital Wide Field Lens combines exceptional wide field views and high magnification. The enhanced double aspheric design and multi-layer coating provide high resolution stereo views of the retin
...ks Super VitreoFundus® provides ultra wide-fie... quick and comprehensive fundus exams at the slit ... a wide field of view through small pupils without...all pupil lenses. Delivering an incredible 124°...
Medicine Products: